Investor's Fiduciary Advisor Network’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.63M Sell
1,777
-33
-2% -$33.5K 0.5% 54
2025
Q4
$1.95M Sell
1,810
-420
-19% -$402K 0.42% 55
2025
Q3
$1.7M Hold
2,230
0.58% 41
2025
Q2
$1.74M Buy
+2,230
New +$1.73M 0.65% 38
2025
Q1
Sell
-3,216
Closed -$2.48M 185
2024
Q4
$2.48M Buy
+3,216
New +$2.66M 0.95% 25

Other funds holding LLY

Investor's Fiduciary Advisor Network's LLY Position: Q1 2026 in Review

Investor's Fiduciary Advisor Network reduced its Eli Lilly (LLY) stake by 1.8% in Q1 2026, selling an estimated $33.5K and leaving 1,777 shares worth $1.63M. The position accounts for 0.5% of the portfolio, ranked #54.

Investor's Fiduciary Advisor Network first reported a position in LLY in Q4 2024 and has held it in 5 quarters since. The position peaked at $2.48M in Q4 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Investor's Fiduciary Advisor Network held 1,777 shares of Eli Lilly worth $1.63M as of Q1 2026.
  • Investor's Fiduciary Advisor Network sold 33 Eli Lilly shares in Q1 2026, an estimated $33.5K.
  • Eli Lilly made up 0.5% of Investor's Fiduciary Advisor Network's portfolio in Q1 2026, its #54 holding.
  • Investor's Fiduciary Advisor Network first reported a position in Eli Lilly in Q4 2024 and has held it in 5 quarters since.
  • Investor's Fiduciary Advisor Network's Eli Lilly position peaked at $2.48M in Q4 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Investor's Fiduciary Advisor Network's 13F filing for Q1 2026, filed 12 May 2026.